Title: Activation of AMPK reduces the co-transporter activity of NKCC1
Authors: Fraser, SA
Davies, M
Katerelos, M
Gleich, K
Choy, SW
Steel, R
Galic, S
Mount, PF
Kemp, BE
Power, DA
Issue Year: 2014
Publisher INFORMA HEALTHCARE
Series MOLECULAR MEMBRANE BIOLOGY: 31(2-Mar): 95-102
Abstract The co-transporter activity of Na+-K+-2Cl(-) 1 (NKCC1) is dependent on phosphorylation. In this study we show the energy-sensing kinase AMPK inhibits NKCC1 activity. Three separate AMPK activators (AICAR, Phenformin and A-769662) inhibited NKCC1 flux in a variety of nucleated cells. Treatment with A-769662 resulted in a reduction of NKCC1(T212/T217) phosphorylation, and this was reversed by treatment with the non-selective AMPK inhibitor Compound C. AMPK dependence was confirmed by treatment of AMPK null mouse embryonic fibroblasts, where A-769662 had no effect on NKCC1 mediated transport. AMPK was found to directly phosphorylate a recombinant human-NKCC1 N-terminal fragment (1-293) with the phosphorylated site identified as S77. Mutation of Serine 77 to Alanine partially prevented the inhibitory effect of A-769662 on NKCC1 activity. In conclusion, AMPK can act to reduce NKCC1-mediated transport. While the exact mechanism is still unclear there is evidence for both a direct effect on phosphorylation of S77 and reduced phosphorylation of T212/217.
URI: https://publications.svi.edu.au/publications/1743
Other Identifiers 10.3109/09687688.2014.902128
Publication type Article
Find it online http://informahealthcare.com/doi/abs/10.3109/09687688.2014.902128